Alantra advises Analytical Wizards on its sale to Definitive Healthcare Corp.

SECTORHealthcare; Technology


Feb 2022
Sell-side advisory

New York – Alantra is pleased to announce that it has advised Analytical Wizards, a healthcare data analytics & technology company focused on the life sciences industry, on its sale to Definitive Healthcare Corp. (NASDAQ: DH), an industry leader in healthcare commercial intelligence.

The Alantra team previously advised Analytical Wizards on a minority investment from Definitive Healthcare in December 2021. In early 2022, Definitive Healthcare exercised its option to purchase the remaining shares of Analytical Wizards & closed the full acquisition in February 2022.

Founded in 2016, Analytical Wizards is a cloud-based data analytics & technology company for the life sciences industry with a focus on providing data-informed decision-making insights to clinical and commercial teams. Analytical Wizards delivers unprecedented scale, productivity gains, and efficiency in healthcare analytics through cutting-edge technology, artificial intelligence, machine learning, life sciences domain, and data science expertise. The company has approximately 150 employees globally.

“The Alantra team was an incredible partner to Analytical Wizards in helping us navigate through the sale process, from clearly articulating our value proposition to steering us through the various stages of a complex transaction with multiple stakeholders,” said Ram Sharma, CEO of Analytical Wizards. “Every team member—from the partners to the analysts—is a high energy, engaged team player who is responsive and delivers results.”

“We are privileged to have collaborated with the talented board and management team of Analytical Wizards on this transformative acquisition by Definitive Healthcare,” said Frederic Laurier, Managing Director with Alantra. “Analytical Wizards is pioneering a novel way of providing the biopharmaceutical industry with actionable insights to accelerate clinical processes and improve commercialization of therapies. This deal reinforces Alantra’s position as a trusted advisor to Healthcare and Life Sciences analytical solution vendors.”

Alantra acted as sole financial advisor to Analytical Wizards on this transaction. The Alantra US Healthcare team advising Analytical Wizards included Mr. Laurier, Bob Cronin (Managing Director), Christian Carlson, PhD (Director), Darius Kuddo (Analyst), and Michaela Zhang (Analyst).

Related Transactions